OLIGONUKLEOTIDKONJUGATE

European patent · EP2920304 · In force

Register entry

Publication number
EP2920304
Application number
EP13791808
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Nov 14, 2013
Published
Sep 23, 2015
Granted
Mar 6, 2019
Protection ends at the latest
Nov 13, 2033
Next annual fee due
Nov 30, 2026
IPC classes
C12N 15/11 (2006.01)
C12N 15/113 (2010.01)
Priority
EP 12192773 15.11.2012
EP 13153296 30.01.2013
EP 13157237 28.02.2013
EP 13174092 27.06.2013
PCT application
PCT/EP2013/073858 14.11.2013
PCT publication
WO2014/076195 22.05.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 1, 2025

    Change

    Published in Swissreg on 01.12.2025

  2. Feb 21, 2025

    Holder’s address changed

    Owner
    Roche Innovation Center Copenhagen A/S, Fremtidsvej 3, 2970 Hørsholm, Denmark → RICC A/S, c/o Roche Diagnostics A/S, Flaskehalsen 17, 4., 1799 Kobenhavn V, Denmark

    Published in Swissreg on 21.02.2025

  3. Dec 1, 2024

    Change

    Published in Swissreg on 01.12.2024

  4. Dec 1, 2023

    Change

    Published in Swissreg on 01.12.2023

  5. Dec 1, 2022

    Change

    Published in Swissreg on 01.12.2022

  6. Mar 6, 2019

    Granted

    Published in Swissreg on 06.03.2019

Parties

Holder

RICC A/S

c/o Roche Diagnostics A/S Flaskehalsen 17, 4., 1799 Kobenhavn V, DK

Inventor

HANSEN, Henrik Frydenlund

DK-4100 Ringsted, DK

ALBÆK, Nanna

DK-3460 Birkerød, DK

RAVN, Jacob

DK-2740 Skovlunde, DK

ØRUM, Henrik

DK-3500 Værløse, DK

KAMMLER, Susanne

DK-2840 Holte, DK

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.